Christian Marin-Muller's Contact Details

Christian Marin-Muller's Company Details

Speratum Biopharma, Inc.

Dover, Delaware, United States • 10 Employees
Research

Speratum is a cancer therapeutics company exploring a new frontier in the fight against cancer which targets the pathways that give rise to cancer using microRNA-based oncology therapy. Our lead candidate is a microRNA therapeutic against pancreatic cancer, offering hope for a potential treatment to this devastating disease.MicroRNA therapy is a bright future for cancer treatments. MicroRNAs are small molecules of RNA (ribonucleic acid) that are naturally occurring in the human body. Their job is to regulate and fine-tune the expression of genes, and in this way they are involved in regulating almost all aspects of human biology, including cancer. A single microRNA can regulate hundreds of genes. When this microRNA becomes dysregulated, various members of a multifactorial pathway lose their controlling element, and cancer-promoting pathways are activated.At Speratum, our mission is to synthetically replace lost microRNAs through our patented therapies and restore their original control over these cancer networks which reverses cancer aggressiveness.